We found that the relationship between the expression pattern of GLS2 and the clinical outcome of most types of cancer was substantially different for GLS. A significant positive correlation between GLS2 overexpression and poor OS was observed in patients with colon, blood, ovarian, and thymoma cancer (Figure 6b(iii,v,vii,x)). This evidence concerns the gene GLS2 and cancer.